Modulation of memory fields by dopamine Dl receptors in prefrontal cortex

Williams, Graham V., Goldman-Rakic, Patricia S.·1995·Nature

Cited by (1,002)

Items 701–800 of 1,002

  1. Differential dopaminergic modulation of executive control in healthy subjects
    Roesch-Ely, Daniela, Scheffel, Hans, Weiland, Stephan, Schwaninger, Markus, Hundemer, Hans-Peter, Kolter, Thomas, Weisbrod, Matthias · 2005 · Psychopharmacology
  2. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia
    Taryn G. Moss, Kristi A. Sacco, Taryn M. Allen, Andrea H. Weinberger, Jennifer C. Vessicchio, Tony Peter George · 2009 · Drug and Alcohol Dependence
  3. Background Dopamine Concentration Dependently Facilitates Long-term Potentiation in Rat Prefrontal Cortex through Postsynaptic Activation of Extracellular Signal-Regulated Kinases
    B. P. Kolomiets, Aude Marzo, Jocelyne Caboche, Peter Vanhoutte, Satoru Otani · 2009 · Cerebral Cortex
  4. Dopamine D1receptor‐mediated enhancement of NMDA receptor trafficking requires rapid PKC‐dependent synaptic insertion in the prefrontal neurons
    Yanchun Li, Gang Liu, Jianli Hu, Wen‐Jun Gao, Yue‐Qiao Huang · 2010 · Journal of Neurochemistry
  5. Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys
    Stefani N. Von Huben, Sophia A. Davis, Christopher C. Lay, Simon N. Katner, Rebecca D. Crean, Michael A. Taffe · 2006 · Psychopharmacology
  6. Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence
    Robbert W. K. Borgemeester, Andrew John Lees, Teus van Laar · 2016 · Parkinsonism & Related Disorders
  7. Chapter 15 Persistent neural activity in the prefrontal cortex: A mechanism by which BDNF regulates working memory?
    Evan M. Galloway, Newton H. Woo, Bai Lu · 2008 · Progress in brain research
  8. Low Doses of Δ-9 Tetrahydrocannabinol (THC) Have Divergent Effects on Short-Term Spatial Memory in Young, Healthy Adults
    Petra Mäkelä, Judi Wakeley, Harm J. Gijsman, Phillip J Robson, Zubin Bhagwagar, Robert David Rogers · 2005 · Neuropsychopharmacology
  9. Differential effects of atypical and typical antipsychotic drugs on N‐methyl‐D‐aspartate‐ and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex
    Ipe Ninan, Kent E. Jardemark, Rex Y. Wang · 2003 · Synapse
  10. Pharmacological and therapeutic directions in ADHD: Specificity in the PFC
    Florence Lévy · 2008 · Behavioral and Brain Functions
  11. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: Involvement of ERK1/2 signaling
    Konstantinos Sarantis, Nikolaos A. Matsokis, Fevronia Angelatou · 2009 · Neuroscience
  12. A prospective study of severe hypoglycemia and long-term spatial memory in children with type 1 diabetes
    Tamara G. Hershey, Rema Lillie, Michelle Sadler, Neil H. White · 2004 · Pediatric Diabetes
  13. Rule-based category learning in patients with Parkinson's disease
    Amanda L. Price, J. Vincent Filoteo, W. Todd Maddox · 2009 · Neuropsychologia
  14. From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
    F. Busardò, Chrystalla Kyriakou, L. Cipolloni, S. Zaami, P. Frati · 2016 · Current Neuropharmacology
  15. Personalized learning: From neurogenetics of behaviors to designing optimal language training
    Patrick C. M. Wong, Loan C. Vuong, Kevin Liu · 2016 · Neuropsychologia
  16. Spatial learning efficiency and error monitoring in normal aging: An investigation using a novel hidden maze learning test
    R PIETRZAK, Henrí Cohen, Peter Jeffrey Snyder · 2007 · Archives of Clinical Neuropsychology
  17. Attenuation of Delay-Period Activity of Monkey Prefrontal Neurons by an α2-Adrenergic Antagonist During an Oculomotor Delayed-Response Task
    Toshiyuki Sawaguchi · 1998 · Journal of Neurophysiology
  18. Dopamine D1 Receptor Activation in the Medial Prefrontal Cortex Prevents the Expression of Cocaine Sensitization
    Barbara A. Sorg, N Li, Weiran Wu · 2001 · Journal of Pharmacology and Experimental Therapeutics
  19. Consequences of Dopaminergic Denervation on the Metabolic Activity of the Cortical Neurons Projecting to the Subthalamic Nucleus in the Rat
    Gaël Orieux, Chantal François, Jean Féger, Étienne C. Hirsch · 2002 · Journal of Neuroscience
  20. Genetic influence on the working memory circuitry: Behavior, structure, function and extensions to illness
    Katherine H. Karlsgodt, Peter Bachman, Anderson M. Winkler, Carrie E. Bearden, David C. Glahn · 2011 · Behavioural Brain Research
  21. Differential Influence of Levodopa on Reward-Based Learning in Parkinson's Disease
    Susanne Graef, Guido Biele, Lea K. Krugel, Frank Marzinzik, Michael Wahl, Johann Wotka, Fabian Klostermann, Hauke R. Heekeren · 2010 · Frontiers in Human Neuroscience
  22. Distinct Physiological Effects of Dopamine D4 Receptors on Prefrontal Cortical Pyramidal Neurons and Fast-Spiking Interneurons
    Ping Zhong, Zhen Yan · 2014 · Cerebral Cortex
  23. Electrically Controlled Neurochemical Release from Dual‐Layer Conducting Polymer Films for Precise Modulation of Neural Network Activity in Rat Barrel Cortex
    Zhanhong Jeff Du, Guo‐Qiang Bi, Xinyan Tracy Cui · 2017 · Advanced Functional Materials
  24. Key periods of cognitive decline in a nonhuman primate model of cognitive aging, the common marmoset (Callithrix jacchus)
    Amirouche Sadoun, Maxime Rosito, Caroline Fonta, Pascal Girard · 2018 · Neurobiology of Aging
  25. Islet injury induces neurotrophin expression in pancreatic cells and reactive gliosis of peri-islet Schwann cells
    Gladys Teitelman, Yelena Guz, Sanja Ivković, Michelle E. Ehrlich · 1998 · Journal of Neurobiology
  26. Modification of dopamine D1 receptor knockout phenotype in mice lacking both dopamine D1 and D3 receptors
    Joanna M. Karasinska, Susan R. George, Mufida El-Ghundi, Paul J. Fletcher, Brian F. O’Dowd · 2000 · European Journal of Pharmacology
  27. Impaired Comprehension of Raising-to-Subject Constructions in Parkinson's Disease
    David L. Kemmerer · 1999 · Brain and Language
  28. Dopamine D1 and D5 Receptors Are Localized to Discrete Populations of Interneurons in Primate Prefrontal Cortex
    Jill R. Glausier, Zafar U. Khan, EC Muly · 2008 · Cerebral Cortex
  29. Aversive Motivation and Cognitive Control
    Debbie Marianne Yee, Xiamin Leng, Amitai Shenhav, Todd Samuel Braver · 2021 · Neuroscience and Biobehavioral Reviews
  30. Muscarinic M1 Receptor Overstimulation Disrupts Working Memory Activity for Rules in Primate Prefrontal Cortex
    Vijayraghavan, Susheel, Major, Alex James, Everling, Stefan · 2018 · Neuron
  31. From attention to memory along the dorsal-ventral axis of the medial prefrontal cortex: some methodological considerations
    Helen Joan Cassaday · 2014 · Frontiers in Systems Neuroscience
  32. Neuropsychopharmacological regulation of performance on creativity-related tasks
    David Quentin Beversdorf · 2018 · Current Opinion in Behavioral Sciences
  33. Computerized and traditional Stroop task dysfunction in HIV-1 infection.
    Charles H. Hinkin, Steven A. Castellon, David J. Hardy, Eric L. Granholm, Greg J. Siegle · 1999 · Neuropsychology
  34. Is dopamine a missing link?
    Robert Desimone · 1995 · Nature
  35. Roles of Fragile X Mental Retardation Protein in Dopaminergic Stimulation-induced Synapse-associated Protein Synthesis and Subsequent α-Amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) Receptor Internalization
    Wang, Hansen, Kim, Susan S., Zhuo, Min · 2010 · Journal of Biological Chemistry
  36. 8,9-Dihydroxy-2,3,7,11b-tetrahydro-1 H -naph[1,2,3- de ]isoquinoline: A Potent Full Dopamine D 1 Agonist Containing a Rigid β-Phenyldopamine Pharmacophore
    Debasis Ghosh, Scott E. Snyder, Val J. Watts, Richard B. Mailman, David E. Nichols · 1996 · Journal of Medicinal Chemistry
  37. Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study
    Cynthia H.Y. Fu, Kathryn Mary Abel, Matthew P. G. Allin, David Gasston, Sergi G. Costafreda, John Suckling A, Steven Williams, Philip K. McGuire · 2005 · Psychopharmacology
  38. Trans-generational Effects of Early Life Stress: The Role of Maternal Behavior
    Claudia Schmauss, Zoe Lee-McDermott, Liorimar Ramos-Medina · 2014 · Scientific Reports
  39. Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics
    Andreas Stevens, J x FC rgen Schwarz, Benedikt Schwarz, Ilona Ruf, Thomas Kolter, Joerg Czekalla · 2002 · Psychopharmacology
  40. COMT as a Drug Target for Cognitive Functions and Dysfunctions
    Diego Scheggia, Sara Sannino, María Luisa Scattoni, Francesco Papaleo · 2012 · CNS & Neurological Disorders - Drug Targets
  41. Early-Life Benzo[a]Pyrene Exposure Causes Neurodegenerative Syndromes in Adult Zebrafish (Danio rerio) and the Mechanism Involved
    Dongxu Gao, Chonggang Wang, Zhihui Xi, Yixi Zhou, Yuanchuan Wang, Zhenghong Zuo · 2017 · Toxicological Sciences
  42. A novel dopamine D1 receptor agonist excites delay-dependent working memory-related neuronal firing in primate dorsolateral prefrontal cortex
    Min Wang, Dibyadeep Datta, John F. Enwright, Veronica C. Galvin, Shengtao Yang, Constantinos D. Paspalas, Rouba Kozak, David L. Gray, David A. Lewis, Amy F.T. Arnsten · 2019 · Neuropharmacology
  43. The Dopamine System in Mediating Alcohol Effects in Humans
    Katrin Charlet, Anne Beck, Andreas Heinz · 2011 · Current topics in behavioral neurosciences
  44. Inverse Agonist Properties of Dopaminergic Antagonists at the D1A Dopamine Receptor: Uncoupling of the D1ADopamine Receptor from Gs Protein
    Guoping Cai, Hakan Gürdal, Candyce I. Smith, Hoau-Yan Wang, Eitan Friedman · 1999 · Molecular Pharmacology
  45. Dopamine D1 receptor stimulation modulates the formation and retrieval of novel object recognition memory: role of the prelimbic cortex
    Pezze, Marie A., Marshall, Hayley J., Fone, Kevin C.F., Cassaday, Helen J. · 2015 · European Neuropsychopharmacology
  46. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder
    Márcio Gerhardt Soeiro‐de‐Souza, Rodrigo Machado‐Vieira, Danielle Soares Bio, Carolina Martins do Prado, Ricardo Alberto Moreno · 2012 · Bipolar Disorders
  47. Adaptation of Prefrontal Cortical Firing Patterns and Their Fidelity to Changes in Action–Reward Contingencies
    William J. Kargo, Botond Szatmáry, Douglas A. Nitz · 2007 · Journal of Neuroscience
  48. Verbal and spatial working memory performance among HIV-infected adults
    Charles H. Hinkin, David J. Hardy, Karen I. Mason, Steven A. Castellon, Mona N. Lam, MARTA STEFANIAK, Bryan Zolnikov · 2002 · Journal of the International Neuropsychological Society
  49. Monoaminergic control of brain states and sensory processing: Existing knowledge and recent insights obtained with optogenetics
    Magor L. Lörincz, Antoine Adamantidis · 2016 · Progress in Neurobiology
  50. Distinct Medial Temporal Lobe Network States as Neural Contexts for Motivated Memory Formation
    Vishnu P. Murty, R. Alison Adcock · 2017 · Springer eBooks
  51. Opiate-associated contextual memory formation and retrieval are differentially modulated by dopamine D1 and D2 signaling in hippocampal–prefrontal connectivity
    Yunpeng Wang, Hongying Zhang, Jingjing Cui, Jing Zhang, Fangyuan Yin, Hao Guo, Jianghua Lai, Bo Xing · 2018 · Neuropsychopharmacology
  52. Medial prefrontal cortical output neurons to the ventral tegmental area (VTA) and their responses to burst-patterned stimulation of the VTA: Neuroanatomical and in vivo electrophysiological analyses
    Simon Au Young, Hao Shen, Charles R. Yang · 1999 · Synapse
  53. Differential effects of COMT on gait and executive control in aging
    Roee Holtzer, Laurie J. Ozelius, Xiaonan Xue, Tzu Chien Wang, Richard B. Lipton, Joe Verghese · 2008 · Neurobiology of Aging
  54. Frontal Cognitive Impairments and Saccadic Deficits in Low-Dose MPTP-Treated Monkeys
    Hamutal Slovin, Moshe Abeles, Eilon Vaadia, Iris Haalman, Yifat Prut, Hagai Bergman · 1999 · Journal of Neurophysiology
  55. Doping the Mind
    Ajit Ranganath, Simon N. Jacob · 2015 · The Neuroscientist
  56. Attention and visual dysfunction in Parkinson's disease
    Hugo Botha, Jonathan Ambrose Carr · 2012 · Parkinsonism & Related Disorders
  57. Dopamine D1 and D4 Receptor Subtypes Differentially Modulate Recurrent Excitatory Synapses in Prefrontal Cortical Pyramidal Neurons
    Shao‐Pii Onn, Xiao-Bin Wang, Min Lin, Anthony A. Grace · 2005 · Neuropsychopharmacology
  58. Functions of delay-period activity in the prefrontal cortex and mnemonic scotomas revisited
    Shintaro Funahashi · 2015 · Frontiers in Systems Neuroscience
  59. Infusion of D1 Dopamine Receptor Agonist into Medial Frontal Cortex Disrupts Neural Correlates of Interval Timing
    Krystal Lynn Parker, Rafael Naime Ruggiero, Nandakumar S. Narayanan · 2015 · Frontiers in Behavioral Neuroscience
  60. Ethanol Dependence Abolishes Monoamine and GIRK (Kir3) Channel Inhibition of Orbitofrontal Cortex Excitability
    Sudarat Nimitvilai, Marcelo F. Lopez, Patrick J. Mulholland, John J. Woodward · 2017 · Neuropsychopharmacology
  61. Entorhinal Cortex Atrophy in Early, Drug-naive Parkinson’s Disease with Mild Cognitive Impairment
    Xiuqin Jia, Zhijiang Wang, Tao Yang, Ying Li, Shuai Gao, Guorong Wu A, Tao Jiang, Peipeng Liang · 2018 · Aging and Disease
  62. Chapter VI Dopamine systems in the primate brain
    David A. Lewis, Susan R. Sesack · 1997 · Handbook of chemical neuroanatomy
  63. Dopaminergic Modulation of Short-Term Synaptic Plasticity in Fast-Spiking Interneurons of Primate Dorsolateral Prefrontal Cortex
    Guillermo González‐Burgos, Sven Kroener, Jeremy Keith Seamans, David A. Lewis, Germán Barrionuevo · 2005 · Journal of Neurophysiology
  64. Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us?
    Anissa Abi‐Dargham · 2003 · PubMed
  65. Mesolimbic Neuronal Activity across Behavioral States
    Donald J. Woodward, JING‐YU CHANG, Patricia H. Janak, Alexey V. Azarov, Kristin K. Anstrom · 1999 · Annals of the New York Academy of Sciences
  66. What can research on schizophrenia tell us about the cognitive neuroscience of working memory?
    Deanna M. Barch · 2005 · Neuroscience
  67. The effects of local application of D2 selective dopaminergic drugs into the medial prefrontal cortex of rats in a delayed spatial choice task
    Druzin, Michael Y, Kurzina, Natalia P, Malinina, Evgenya P, Kozlov, Andrej P · 2000 · Behavioural Brain Research
  68. Cell-type-specific modulation of targets and distractors by dopamine D1 receptors in primate prefrontal cortex
    Simon N. Jacob, Maximilian Stalter, Andreas Nieder · 2016 · Nature Communications
  69. Activating Developmental Reserve Capacity Via Cognitive Training or Non-invasive Brain Stimulation: Potentials for Promoting Fronto-Parietal and Hippocampal-Striatal Network Functions in Old Age
    Susanne Passow, Franka Thurm, Shu Li · 2017 · Frontiers in Aging Neuroscience
  70. A functional magnetic resonance imaging study of the effects of pergolide, a dopamine receptor agonist, on component processes of working memory
    Gibbs, S.E.B., D’Esposito, M. · 2006 · Neuroscience
  71. Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response
    Rudi Hwang, Takahiro Shinkai, Vincenzo De Luca, Xingqun Ni, Steven G. Potkin, Jeffrey Alan Lieberman, Herbert Y. Meltzer, James L. Kennedy · 2006 · Journal of Psychopharmacology
  72. Sequential movement skill in Parkinson's disease: A state-of-the-art
    Marit F. L. Ruitenberg, Wout Duthoo, Patrick Santens, Wim Notebaert, Elger L. Abrahamse · 2015 · Cortex
  73. Switching schizophrenia patients from typical neuroleptics to aripiprazole: Effects on working memory dependent functional activation
    Florian Schlagenhauf, Martin Dinges, Anne Beck, Torsten Wüstenberg, Eva Friedel, Theresa Dembler, Rahul Sarkar, Jana Wrase, Jürgen Gallinat, Georg Juckel et al. · 2010 · Schizophrenia Research
  74. Dynamics of action potential backpropagation in basal dendrites of prefrontal cortical pyramidal neurons
    Wen‐Liang Zhou, Ping Yan, Joseph P. Wuskell, Leslie M. Loew, Srdjan D. Antic · 2008 · European Journal of Neuroscience
  75. Role of glutamate in schizophrenia: integrating excitatory avenues of research
    Monsheel Sodhi, Kimberly H. Wood, James H. Meador‐Woodruff · 2008 · Expert Review of Neurotherapeutics
  76. Differential increase of extracellular dopamine and serotonin in the ‘prefrontal cortex’ and striatum of pigeons during working memory
    Dilek Karakuyu, Christina Herold, Onur Güntürkün, Bettina Diekamp · 2007 · European Journal of Neuroscience
  77. Perceptual Color Space Representations in the Oculomotor System Are Modulated by Surround Suppression and Biased Selection
    Devin Heinze Kehoe, Maryam Rahimi, Mazyar Fallah · 2018 · Frontiers in Systems Neuroscience
  78. Levodopa and executive performance in Parkinson's disease: A randomized study
    Berta Pascual‐Sedano, Jaime Kulisevsky, Manel J. Barbanoj, Carmen García‐Sánchez, Antònia Campolongo, Alexandre Gironell, Javier Pagonabarraga, Ignasi J. Gich · 2008 · Journal of the International Neuropsychological Society
  79. Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
    Kim, Soyoun, Bobeica, Irina, Gamo, Nao J., Arnsten, Amy F. T., Lee, Daeyeol · 2012 · Psychopharmacology
  80. Cocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system
    Matthew C. Hearing, Anastasia N. Zink, Kevin Wickman · 2012 · Reviews in the Neurosciences
  81. Preliminary evidence that allelic variation in the LMX1A gene influences training-related working memory improvement
    Martin Bellander, Yvonne Brehmer, Helena Westerberg, Sari Karlsson, Daniel Fürth, Olle Bergman, Elias Eriksson, Lars Bäckman · 2011 · Neuropsychologia
  82. Markers of cognitive decline in PD: The case for heterogeneity
    Oury Monchi, Alexandru Hanganu, Pierre Bellec · 2016 · Parkinsonism & Related Disorders
  83. Dopaminergic Modulation of Synaptic Plasticity, Its Role in Neuropsychiatric Disorders, and Its Computational Modeling
    Mojtaba Madadi Asl, Abdol‐Hossein Vahabie, Alireza Valizadeh · 2018 · Basic and Clinical Neuroscience Journal
  84. Executive Attention in Schizophrenic Males and the Impact of COMT Val108/158Met Genotype on Performance on the Attention Network Test
    Carolin Opgen‐Rhein, Andres H. Neuhaus, Carsten Urbanek, Eric W. Hahn, Thomas Sander, Michael Dettling · 2008 · Schizophrenia Bulletin
  85. Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action
    Patrick D. Roberts, Äthan Spiros, Hugo Geerts · 2012 · Alzheimer s Research & Therapy
  86. Blunted brain metabolic response to ketamine in mice lacking D1A dopamine receptors
    Seiya Miyamoto, Richard B. Mailman, Jeffrey Alan Lieberman, Gary E. Duncan · 2001 · Brain Research
  87. Subcellular Distribution of Neurabin Immunolabeling in Primate Prefrontal Cortex: Comparison with Spinophilin
    E. Chris Muly · 2004 · Cerebral Cortex
  88. Comparison of the Ligand Binding and Signaling Properties of Human Dopamine D2 and D3 Receptors in Chinese Hamster Ovary Cells
    Jurgen F.M. Vanhauwe, Norbert Fraeyman, Bart J. B. Francken, Walter H. M. L. Luyten, Jos�e E. Leysen · 1999 · Journal of Pharmacology and Experimental Therapeutics
  89. Cognitive effects of olanzapine treatment in schizophrenia.
    Susan R. McGurk, M A Lee, Karu Jayathilake, Herbert Y. Meltzer · 2004 · PubMed Central
  90. Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease
    Sean James Fallon, Katrijn Smulders, Rianne A.J. Esselink, Bart P.C. van de Warrenburg, Bastiaan R. Bloem, Roshan Cools · 2015 · Neuropsychologia
  91. Selective overexpression of Comt in prefrontal cortex rescues schizophrenia-like phenotypes in a mouse model of 22q11 deletion syndrome
    Sohei Kimoto, Kazue Muraki, Michihiro Toritsuka, Shin-ichiro Mugikura, Kagemasa Kajiwara, Taishiro Kishimoto, Elizabeth A. Illingworth, Kenji Tanigaki · 2012 · Translational Psychiatry
  92. Effects of cannabis use status on cognitive function, in males with schizophrenia
    Rachel Allison Rabin, Konstantine K. Zakzanis, Zafiris J. Daskalakis, Tony Peter George · 2012 · Psychiatry Research
  93. Prefrontal D1 dopamine signaling is necessary for temporal expectation during reaction time performance
    Krystal Lynn Parker, Stephanie L. Alberico, Adam Miller, Nandakumar S. Narayanan · 2013 · Neuroscience
  94. Striatum–hippocampus balance: From physiological behavior to interneuronal pathology
    Veronica Ghiglieri, Carmelo Sgobio, Cinzia Costa, Barbara Picconi, Paolo Calabresi · 2011 · Progress in Neurobiology
  95. Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei
    Pablo Moriña Vázquez, Pau Celada, Roser Cortés, Francesc Artigas · 2010 · The International Journal of Neuropsychopharmacology
  96. The Dopamine Agonist Bromocriptine Differentially Affects Fronto-Striatal Functional Connectivity During Working Memory
    Deanna L. Wallace, Jason J. Vytlacil, Emi M. Nomura, Sasha E. B. Gibbs, Mark D’Esposito · 2011 · Frontiers in Human Neuroscience
  97. 5.4 Dopaminergic Modulation of Flexible Cognitive Control in Humans
    Cools, Roshan, D’Esposito, Mark · 2009 · Dopamine Handbook
  98. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease
    Erin R. Foster, KEVIN JOHN BLACK, Jo Ann V. Antenor‐Dorsey, Joel S. Perlmutter, Tamara G. Hershey · 2007 · Brain and Cognition
  99. COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms.
    David A Goldman, Gábor Oroszi, Stephanie S. O’Malley, Raymond F. Anton · 2005 · Journal of Studies on Alcohol Supplement
  100. Differential Effects of Acute Serotonin and Dopamine Depletion on Prepulse Inhibition and P50 Suppression Measures of Sensorimotor and Sensory Gating in Humans
    Collette Mann, Rodney J. Croft, Kirsty E. Scholes‐Balog, Alan Dunne, Barry Vincent O’Neill, Sumie Leung, David Copolov, K. Luan Phan, Pradeep J. Nathan · 2007 · Neuropsychopharmacology